The emerging therapy of tirzepatide peptide represents a significant development in the care of the condition. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide427949.ziblogs.com/42315097/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment